Results for "Understanding Pharmaceutical Distribution"
HDA’s 2023 DMA Winners Discuss DSCSA Credentialing and the Value of Collaboration
With the Drug Supply Chain Security Act (DSCSA) implementation deadline on the horizon, HDA members and industry partners are driving innovative solutions to support trading partner compliance. One of the notable examples of this collaboration is demonstrated by HDA’s 2023 Distribution Management Award (DMA) recipients, Spherity and Legisym.
We spoke with Georg Jürgens, Spherity’s Manager of Industry Solutions, and David Kessler, President and Partner of Legisym, about their companies’ histories, award-winning DSCSA solution and collaboration driving innovation within the healthcare distribution supply chain.
Davis Spotlights HDA's 2021 Strategic Priorities
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.